Trial intelligence / Profile preview

Confu-Riv placebo-controlled double-blind trial of rivastigmine for delirium in adults aged 75 years or older

2009-015632-15Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Sep 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of rivastigmine in delirium (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Time until return home or transfer to rehabilitation/post-acute care. Started Sep 2009; status: active.

02

Drugs

rivastigmine
03

Conditions

delirium

Beyond the preview

Go deeper on 2009-015632-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015632-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call